STOCKHOLM, Dec. 9, 2019 /PRNewswire/ -- IRRAS AB
(NASDAQ Stockholm: IRRAS), a global healthcare company with a
comprehensive portfolio of innovative products for
neurocritical care, announced today that IRRAflow has
been selected as the 2019 winner of CONNECT's Most Innovative New
Product award in the medical device category. CONNECT, a premier
nonprofit helping entrepreneurs with innovative startups in the
technology and life sciences sectors, continues its thirty-two-year
tradition of celebrating innovation leaders in the broader
San Diego area.
IRRAflow, the company's initial commercial product, has a
unique mechanism of action that addresses the complications
associated with the current methods of managing intracranial fluid
by using a dual-lumen catheter that combines automated irrigation,
controlled drainage, and continuous ICP monitoring, all into one
system.
"Our IRRAS team has worked extremely hard to build the
foundation for a legacy company, and it was an honor to be
recognized by our entrepreneurial peers," said Will Martin, IRRAS' Chief Commercial Officer.
"At IRRAS, we are committed to bringing needed innovation to
neurocritical care and this recognition confirms our
commitment."
IRRAflow was awarded in the medical device category at
the annual Innovation Awards event held on Thursday, December 5th, at the Hyatt
Regency La Jolla at Aventine. Winners were selected in the
following seven categories: Big Data; Cleantech; Defense; Medical
Device; Life Science and Healthtech; Smart City &
Transportation, and Software.
For a complete list of winners and additional information,
please visit the CONNECT's website.
About IRRAS
IRRAS AB is a global healthcare company focused on delivering
innovative medical technologies to our customers and their
patients. IRRAS designs, develops and commercializes products that
improve patient outcomes and decrease the overall cost of care by
addressing complications associated with current treatment methods
in neurocritical care. IRRAS markets and sells its products to
hospitals worldwide through its direct sales organizations in the
U.S. and select European countries and a network of distribution
partners in other markets.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS AB (publ) is listed on Nasdaq First North Premier Growth
Market (ticker: IRRAS). Redeye AB is certified adviser of the
company with email certifiedadviser@redeye.se or phone +46 8 121
576 90.
ABOUT CONNECT
For more than 30 years, CONNECT has focused on elevating
entrepreneurs in the San Diego
region. The organization has a long history as a powerhouse of
resources for innovators, including mentorship, education, and
connection to capital. CONNECT serves entrepreneurs and startups
throughout their growth journey, from early stage to capital raise,
with a suite of curated programs and events aimed to help companies
grow, gain access to capital, and scale.
For more information, please contact:
USA
Kleanthis G. Xanthopoulos, Ph.D.
President and CEO
ir@irras.com
Europa
Sabina
Berlin
CFO
+46-73-951-95-02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on December 9, 2019 at 8.00
a.m. (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irraflow--wins-connect-s--2019-most-innovative-new-product--award,c2985618